Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
argues that intensive weight loss can create a POPdriven toxic rebound that partially undermines cardiometabolic benefits and may promote weight regain by mobilizing lipophilic pollutants from adipose into blood and target organs.3 From this publication, we learn that the abrupt rise in circulating POPs during intensive weight loss can: Disturb energy metabolism (resting metabolic rate/sleeping metabolic rate), oxidative enzymes, thyroid axis) Impair insulin action and mitochondrial function Redistribute POPs from adipose to organs (liver, muscle, pancreas, nervous system), increasing cardiometabolic risk The authors summarize clinical data where intentional weight loss improves body weight and some risk factors, but does not fully normalize, or even worsens glucose tolerance, blood lipids, or inflammatory markers
Potential benefits may include: Reduced appetite Feeling full sooner Support for steady weight reduction over time Improved control over cravings and portion sizes Tirzepatide works as a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, helping regulate appetite, support blood-sugar control, and influence how the body uses fat
Prioritize sleep and stress regulation, and keep hydration and fiber consistent
They may be a better fit if youre targeting more substantial weight loss, have had limited success with previous interventions, prefer a low-maintenance routine with minimal daily decisions, or want to reduce variables related to absorption and timing
